Processa Pharmaceuticals, Inc. - Common Stock — Statistiche Finanziarie Trimestrali (NASDAQ:PCSA) | MetaTrader

Apri il grafico completo Full chart

Financials

Panoramica Estratto Conto Statistiche

Trimestrale Annuale

Flusso di cassa derivante dalle attività operative -2.25 M-2.73 M-2.27 M-3.48 M-2.9 M-3.59 M -12.25 M Flussi di cassa derivanti dalle attività di investimento 0———-850 K-500 K — Liquidità derivante dalle attività di finanziamento 547.58 K4.44 M6.31 M2.86 M2.98 M244.78 K 12.39 M Liquidità libera -2.25 M-2.73 M-2.27 M-3.48 M-2.9 M-4.09 M -12.75 M

Notizie

Why Penguin Solutions Shares Are Trading Higher By Over 5%; Here Are 20 Stocks Moving Premarket - AAR (NYSE:AIR), Alpha Modus Holdings (NASDAQ:AMOD)

Processa Pharmaceuticals completes enrollment for NGC-Cap breast cancer study

PCSA Stock Soars on Upbeat Clinical Update From Breast Cancer Study

Why MillerKnoll Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket - Akanda (NASDAQ:AKAN), Actelis Networks (NASDAQ:ASNS)

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.47%

Here’s Why Penny Stock Processa Pharmaceuticals (PCSA) Is Exploding Today - TipRanks.com

Il titolo di Processa Pharmaceuticals sale dopo risultati promettenti del farmaco anticancro

Processa Pharmaceuticals stock soars after cancer drug shows promising results

Processa riporta dati preliminari positivi per terapia contro il cancro

Processa reports positive preliminary data for cancer therapy

Processa Pharmaceuticals annuncia un reverse stock split di 1 a 25 efficace questa settimana

Processa Pharmaceuticals announces 1-for-25 reverse stock split effective this week